Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose.
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose.
Source: RSNA

AI may help reduce gadolinium dose in MRI

Researchers are using artificial intelligence to reduce the dose of a contrast agent that may be left behind in the body after MRI exams, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).

Gadolinium is a heavy metal used in contrast material that enhances images on MRI. Recent studies have found that trace amounts of the metal remain in the bodies of people who have undergone exams with certain types of gadolinium. The effects of this deposition are not known, but radiologists are working proactively to optimize patient safety while preserving the important information that gadolinium-enhanced MRI scans provide. “There is concrete evidence that gadolinium deposits in the brain and body,” said study lead author Enhao Gong, Ph.D., researcher at Stanford University. “While the implications of this are unclear, mitigating potential patient risks while maximizing the clinical value of the MRI exams is imperative.”

Dr. Gong and colleagues at Stanford have been studying deep learning as a way to achieve this goal. Deep learning is a sophisticated artificial intelligence technique that teaches computers by examples. Through use of models called convolutional neural networks, the computer can not only recognize images but also find subtle distinctions among the imaging data that a human observer might not be capable of discerning.

Imaging protocol used with 3 different MR series at different contrast doses.
Imaging protocol used with 3 different MR series at different contrast doses.
Source: RSNA

To train the deep learning algorithm, the researchers used MR images from 200 patients who had received contrast-enhanced MRI exams for a variety of indications. They collected three sets of images for each patient: pre-contrast scans, done prior to contrast administration and referred to as the zero-dose scans; low-dose scans, acquired after 10 percent of the standard gadolinium dose administration; and full-dose scans, acquired after 100 percent dose administration.

The algorithm learned to approximate the full-dose scans from the zero-dose and low-dose images. Neuroradiologists then evaluated the images for contrast enhancement and overall quality.

Results showed that the image quality was not significantly different between the low-dose, algorithm-enhanced MR images and the full-dose, contrast-enhanced MR images. The initial results also demonstrated the potential for creating the equivalent of full-dose, contrast-enhanced MR images without any contrast agent use.

These findings suggest the method’s potential for dramatically reducing gadolinium dose without sacrificing diagnostic quality, according to Dr. Gong. “Low-dose gadolinium images yield significant untapped clinically useful information that is accessible now by using deep learning and AI,” he said.

Now that the researchers have shown that the method is technically possible, they want to study it further in the clinical setting, where Dr. Gong believes it will ultimately find a home. Future research will include evaluation of the algorithm across a broader range of MRI scanners and with different types of contrast agents. “We’re not trying to replace existing imaging technology,” Dr. Gong said. “We’re trying to improve it and generate more value from the existing information while looking out for the safety of our patients.”

Subscribe to our newsletter

Related articles

Deep learning boosts MRI detection of ADHD

Deep learning boosts MRI detection of ADHD

Deep learning can boost the power of MRI in predicting attention deficit hyperactivity disorder (ADHD).

AI distinguishes pneumonia from COVID-19

AI distinguishes pneumonia from COVID-19

Researchers have developed a predictive artificial intelligence model that can tell the difference between healthy patients, those who are ill with pneumonia and those who have COVID-19, from chest X-rays.

Dentistry: AI helps localize the mandibular canals

Dentistry: AI helps localize the mandibular canals

Researchers have developed a new model that accurately and automatically shows the exact location of mandibular canals.

AI may help brain cancer patients avoid biopsy

AI may help brain cancer patients avoid biopsy

Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.

AI accelerates blood flow MRI

AI accelerates blood flow MRI

Researchers have presented a method that could greatly accelerate dynamic magnetic resonance imaging of blood flow.

AI for very young brains

AI for very young brains

Scientists have developed an innovative new technique that uses artificial intelligence to better define the different sections of the brain in newborns during a magnetic resonance imaging (MRI) exam.

AI outperform doctors: Experts express concerns

AI outperform doctors: Experts express concerns

Many studies claiming that AI is as good as (or better than) human experts at interpreting medical images are of poor quality and are arguably exaggerated, warn researchers in The BMJ.

AI & MRI look into the genome of brain tumors

AI & MRI look into the genome of brain tumors

Researcher have developed a computer method that uses MRI and machine learning to rapidly forecast genetic mutations in glioma tumors,

Robotic system for endovascular instrument guidance

Robotic system for endovascular instrument guidance

Researchers have developed a new method to guide endovascular instruments into complex vascular structures that were inaccessible to endovascular surgeons until now.

Popular articles

Photo

AI for very young brains

Scientists have developed an innovative new technique that uses artificial intelligence to better define the different sections of the brain in newborns during a magnetic resonance imaging (MRI) exam.